Cao, Chao, et al. “Risk Profile of Bevacizumab in Patients With Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials”. Acta Oncologica, vol. 51, no. 2, Feb. 2012, pp. 151-6, doi:10.3109/0284186X.2011.631579.